|
Senseonics Announces Equity Grants To Employees Under Inducement Plan
07/03/2019
|
|
|
Senseonics Announces FDA Approval for a Non-Adjunctive Indication (Dosing Claim) for the Eversense® 90-day CGM System
06/06/2019
|
|
|
Senseonics to Present Real-World, Long-Term Safety Data of the First Implantable CGM Sensor at the American Diabetes Association’s 79th Scientific Sessions
06/05/2019
|
|
|
Senseonics to Participate in the Raymond James Life Sciences and MedTech Conference
06/04/2019
|
|
|
Senseonics to Participate in the Guggenheim MedTech Disruptors Summit
05/21/2019
|
|
|
Senseonics Holdings, Inc. Reports First Quarter 2019 Financial Results
05/09/2019
|
|
|
Senseonics Holdings, Inc. Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019 at 4:30 p.m. Eastern Time
04/25/2019
|
|
|
Senseonics Launches the Eversense® Bridge Patient Access Program in the U.S.
03/22/2019
|
|
|
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
03/12/2019
|
|
|
Senseonics Announces Appointment of Francine R. Kaufman, M.D. as Chief Medical Officer
03/06/2019
|
|